Meanwhile, considering that excessive activation of PARP1 consumes a large amount of intracellular NAD+, leading to energy metabolism disorders and further aggravating cell death, we also plan to use NAD+ precursor substances (e.g., β-nicotinamide mononucleotide, NMN) for intervention in subsequent studies. The gene discussed is PARP1; the disease is Other metabolic disease.